BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11861410)

  • 1. Beta-myosin heavy chain gene mutations in familial hypertrophic cardiomyopathy: the usual suspect?
    McNally EM
    Circ Res; 2002 Feb; 90(3):246-7. PubMed ID: 11861410
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
    Blair E; Redwood C; de Jesus Oliveira M; Moolman-Smook JC; Brink P; Corfield VA; Ostman-Smith I; Watkins H
    Circ Res; 2002 Feb; 90(3):263-9. PubMed ID: 11861413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel mutations in exon 21 encoding beta-cardiac myosin heavy chain.
    Moric E; Mazurek U; Połońska J; Domal-Kwiatkowska D; Smolik S; Kozakiewicz K; Tendera M; Wilczok T
    J Appl Genet; 2003; 44(1):103-9. PubMed ID: 12590187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.
    Hougs L; Havndrup O; Bundgaard H; Køber L; Vuust J; Larsen LA; Christiansen M; Andersen PS
    Eur J Hum Genet; 2005 Feb; 13(2):161-5. PubMed ID: 15483641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene.
    Villard E; Duboscq-Bidot L; Charron P; Benaiche A; Conraads V; Sylvius N; Komajda M
    Eur Heart J; 2005 Apr; 26(8):794-803. PubMed ID: 15769782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.
    Semsarian C; Ahmad I; Giewat M; Georgakopoulos D; Schmitt JP; McConnell BK; Reiken S; Mende U; Marks AR; Kass DA; Seidman CE; Seidman JG
    J Clin Invest; 2002 Apr; 109(8):1013-20. PubMed ID: 11956238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric restrictive cardiomyopathy associated with a mutation in beta-myosin heavy chain.
    Ware SM; Quinn ME; Ballard ET; Miller E; Uzark K; Spicer RL
    Clin Genet; 2008 Feb; 73(2):165-70. PubMed ID: 18076673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
    Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypertrophic cardiomyopathy--a case report].
    Domal-Kwiatkowska D; Glanowska G; Smolik S; Wilczewski P; Mazurek U; Nowalany-Kozielska E; Fudal M; Wodniecki J
    Kardiol Pol; 2006 Nov; 64(11):1287-91. PubMed ID: 17165166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
    Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
    Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do the FHC-associated R403 mutations in myosin heavy chain lead to a greater energetic cost of contraction?
    Ingwall JS
    J Mol Cell Cardiol; 2004 Mar; 36(3):327-30. PubMed ID: 15010270
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
    Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
    J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect.
    García-Castro M; Reguero JR; Alvarez V; Batalla A; Soto MI; Albaladejo V; Coto E
    Int J Cardiol; 2005 Jul; 102(3):501-7. PubMed ID: 16004897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.
    Blankenburg R; Hackert K; Wurster S; Deenen R; Seidman JG; Seidman CE; Lohse MJ; Schmitt JP
    Circ Res; 2014 Jul; 115(2):227-37. PubMed ID: 24829265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.